Connor, Clark & Lunn Investment Management Ltd. - VIKING THERAPEUTICS INC ownership

VIKING THERAPEUTICS INC's ticker is VKTX and the CUSIP is 92686J106. A total of 141 filers reported holding VIKING THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 0.44 and the average weighting 0.0%.

Quarter-by-quarter ownership
Connor, Clark & Lunn Investment Management Ltd. ownership history of VIKING THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$845,305
-73.6%
76,360
-61.3%
0.00%
-75.0%
Q2 2023$3,200,032
+112.5%
197,411
+118.3%
0.02%
+100.0%
Q1 2023$1,505,593
+81.5%
90,426
+2.5%
0.01%
+60.0%
Q4 2022$829,512
+17.3%
88,246
-66.0%
0.01%0.0%
Q3 2022$707,000
+9.8%
259,887
+16.6%
0.01%
+25.0%
Q2 2022$644,000
+80.9%
222,862
+87.7%
0.00%
+100.0%
Q1 2022$356,000
+97.8%
118,706
+202.8%
0.00%
+100.0%
Q4 2021$180,000
+20.0%
39,199
+63.7%
0.00%0.0%
Q3 2021$150,000
+78.6%
23,950
+70.9%
0.00%
Q2 2021$84,00014,0110.00%
Other shareholders
VIKING THERAPEUTICS INC shareholders Q4 2021
NameSharesValueWeighting ↓
DAFNA Capital Management LLC 450,900$2,624,0000.85%
Sio Capital Management, LLC 709,780$4,131,0000.82%
KNOTT DAVID M 218,102$1,269,0000.74%
ArrowMark Colorado Holdings LLC 7,988,635$46,494,0000.44%
Park West Asset Management LLC 1,457,507$8,483,0000.33%
VIRTUS ALTERNATIVE INVESTMENT ADVISERS, INC. 1,657$10,0000.18%
Virtus ETF Advisers LLC 42,507$247,0000.13%
Cornerstone Capital, Inc. 125,465$730,0000.10%
L & S Advisors Inc 114,988$669,0000.09%
EXANE DERIVATIVES 44,877$261,170,0000.08%
View complete list of VIKING THERAPEUTICS INC shareholders